Dual inhibition of the renin system by aliskiren and valsartan

Lancet. 2007 Sep 29;370(9593):1126-7. doi: 10.1016/S0140-6736(07)61508-6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Amides / adverse effects
  • Amides / pharmacology*
  • Amides / therapeutic use
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / pharmacology*
  • Antihypertensive Agents / therapeutic use
  • Drug Therapy, Combination
  • Fumarates / adverse effects
  • Fumarates / pharmacology*
  • Fumarates / therapeutic use
  • Humans
  • Hyperkalemia / chemically induced
  • Hypertension / drug therapy
  • Renin / antagonists & inhibitors*
  • Tetrazoles / adverse effects
  • Tetrazoles / pharmacology*
  • Tetrazoles / therapeutic use
  • Valine / adverse effects
  • Valine / analogs & derivatives*
  • Valine / pharmacology
  • Valine / therapeutic use
  • Valsartan

Substances

  • Amides
  • Antihypertensive Agents
  • Fumarates
  • Tetrazoles
  • aliskiren
  • Valsartan
  • Renin
  • Valine